First gene therapy — ‘a true living drug’ — on the cusp of FDA approval – Washington Post
pharmaphorum |
First gene therapy — 'a true living drug' — on the cusp of FDA approval
Washington Post The CAR T-cell treatment, manufactured by the drug company Novartis, initially would be available only for the small number of children and young adults whose leukemia doesn't respond to standard care. Those patients typically have a grim prognosis … Novartis CAR–T safety in FDA spotlight |
